암환자의 불안과 약물치료：근거중심적 고찰

참고문헌 (46)

1. Holland JC, "Anxiety and cancer: the patient and the family", J Clin Psychiatry, 50(Suppl), pp.20~25 (1989)
2. Razavi D, "Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebocontrolled study assessing the usefulness of alprazolam", J Clin Oncol, 11, pp.1384~1390 (1993)
3. Andrykowski MA, "Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer", Cancer, 62, pp.2607~2613 (1988)
4. EM P, "Help in the dying process", American handbook of psychiatry S Arieti, 1, pp.685~704 (1974)
5. Holland JC, "Pathways for psychosocial care of cancer survivors", Cancer, 104, pp.2624~2637 (2005)
6. Wells KB, "Psychiatric disorder in a sample of the general population with and without chronic medical conditions", Am J Psychiatry, 145, pp.976~981 (1988)
7. Fallowfield LJ, "Psychological effects of being offered choice of surgery for breast cancer", BMJ, 309, pp.448~ (1994)
8. Kissane DW, "Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis", Aust N Z J Psychiatry, 38, pp.320~326 (2004)
9. Scottish Intercollegiate Guidelines Network, "SIGN 50: a guideline developer’s handbook", ~ (2008)
10. Stiefel F, "Psychopharmacology in supportive care in cancer: a review for the clinician. I. Benzodiazepines", Support Care Cancer, 7, pp.379~385 (1999)
11. Greenberg DB, "Strategic use of benzodiazepines in cancer patients", Oncology (Williston Park), 5, pp.83~88 (1991)
12. Triozzi PL, "Contributions of benzodiazepines to cancer therapy", Cancer Invest, 6, pp.103~111 (1988)
13. Massie MJ, "Management of depression and anxiety in cancer patients IN handbook of psychiatric aspects of symptom management in cancer patients", pp.1~21 (1993), American Psychiatric Press
14. Stark DP, "Anxiety in cancer patients", Br J Cancer, 83, pp.1261~1267 (2000)
15. Gaudreau JD, "Psychoactive medications and risk of deliriHarin hospitalized cancer patients", J Clin Oncol, 23, pp.6712~6718 (2005)
16. Massie MJ, "Handbook of psychooncology: psychological care of the patient with cancer" (1989), Oxford University Press
17. Bishop JF, "Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine", J Clin Oncol, 2, pp.691~695 (1984)
18. Kris MG, "Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial", Cancer, 60, pp.2816~2822 (1987)
19. Holland JC, "A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms", J Clin Oncol, 9, pp.1004~1011 (1991)
20. Marik PE, "Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine", Crit Care Med, 36, pp.1937~1949 (2008)
21. Sandler ES, "Midazolam versus fentanyl as premedication for painful procedures in children with cancer", Pediatrics, 89, pp.631~634 (1992)
22. Ljungman G, "Midazolam nasal spray reduces procedural anxiety in children", Pediatrics, 105, pp.73~78 (2000)
23. Kim HF, "Antidepressant use in ambulatory cancer patients", Curr Oncol Rep, 8, pp.275~281 (2006)
24. Berard RM, "Depression and anxiety in oncology: the psychiatrist’s perspective", J Clin Psychiatry, 62(Suppl 8), pp.58~61 (2001)
25. Razavi D, "The effect of fluoxetine on anxiety and depression symptoms in cancer patients", Acta Psychiatr Scand, 94, pp.205~210 (1996)
26. Stockler MR, "Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebocontrolled double-blind randomised trial", Lancet Oncol, 8, pp.603~612 (2007)
27. Rao N, "The clinical pharmacokinetics of escitalopram", Clin Pharmacokinet, 46, pp.281~290 (2007)
28. Barton DL, "Pilot evaluation of citalopram for the relief of hot flashes", J Support Oncol, 1, pp.47~51 (2003)
29. Musselman DL, "Paroxetine for the prevention of depression induced by high-dose interferon alfa", N Engl J Med, 344, pp.961~966 (2001)
30. Stearns V, "A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors", Ann Oncol, 11, pp.17~22 (2000)
31. Gothelf D, "Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer", J Am Acad Child Adolesc Psychiatry, 44, pp.1258~1262 (2005)
32. Kast RE, "Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy", Support Care Cancer, 9, pp.469~470 (2001)
33. Thompson DS, "Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology", Psychosomatics, 41, pp.356~359 (2000)
34. Cankurtaran ES, "Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine", Support Care Cancer, 16, pp.1291~1298 (2008)
35. Pasquini M, "Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division", Depress Anxiety, 23, pp.441~448 (2006)
36. Barman Balfour JA, "Venlafaxine extended-release: a review of its clinical potential in the management of generalised anxiety disorder", CNS Drugs, 14, pp.483~503 (2000)
37. Tasmuth T, "Venlafaxine in neuropathic pain following treatment of breast cancer", Eur J Pain, 6, pp.17~24 (2002)
38. Loibl S, "Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients-a double-blind, randomized study", Ann Oncol, 18, pp.689~693 (2007)
39. Loprinzi CL, "Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial", Lancet, 356, pp.2059~2063 (2000)
40. Nelson HD, "Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis", JAMA, 295, pp.2057~2071 (2006)
41. Gill D, "Antidepressants for depression in medical illness", Cochrane Database Syst Rev, 4, pp.CD001312~ (2000)
42. Mazzocato C, "Psychopharmacology in supportive care of cancer: a review for the clinician: II. Neuroleptics", Support Care Cancer, 8, pp.89~97 (2000)
43. Winell J, "Psychiatric assessment and symptom management in elderly cancer patients", Oncology (Williston Park), 19, pp.1479~1490 (2005)
44. Khojainova N, "Olanzapine in the management of cancer pain", J Pain Symptom Manage, 23, pp.346~350 (2002)
45. Navari RM, "A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study", Support Care Cancer, 13, pp.529~534 (2005)
46. Miovic M, "Psychiatric disorders in advanced cancer", Cancer, 110, pp.1665~1676 (2007)

관련 논문AI추천